Trends and Finance: Page 2

Agilent to sell Resolution Bioscience to Exact Sciences

Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.

September 12, 2023

Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology

Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.

September 6, 2023

LabGenomics USA acquires QDx Pathology

In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.

September 6, 2023

Ga. lab owner sentenced for $463M Medicare testing fraud scheme

Ga. lab owner Minal Patel was sentenced to serve 27 years in prison following his December 2022 conviction for his role in a $463 million Medicare fraud scheme.

September 8, 2023

Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development

Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.

September 5, 2023

Ginkgo Bioworks, Google Cloud to collaborate on AI tools

Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.

September 6, 2023

Oxford Nanopore, IQVIA form nanopore sequencing partnership

Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.

August 31, 2023

Danaher to acquire Abcam for $5.7B

Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.

August 29, 2023

CrisprBits, MolBio Diagnostics to collaborate on POC tests

The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.

August 23, 2023

Viome Life Sciences raises $86.5M in Series C financing round

This round brings Viome's total financing to $175 million, the firm said. A previous Series C financing round in October raised $67 million.

August 21, 2023

Agilent closes $550M liquid biopsy unit after failing to find path to profits

When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.

August 18, 2023

Visiopharm, Boston Cell Standards team up to support higher assay requirements

If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.

August 17, 2023

Previous Page

Page 2 of 123

Next Page